Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD et al (2019) Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576:112–120. https://doi.org/10.1038/s41586-019-1775-1

Article  CAS  Google Scholar 

Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, Rodriguez FJ, Cahill DP, McLendon R, Riggins G et al (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453–1455. https://doi.org/10.1126/science.1210557

Article  CAS  Google Scholar 

Bowman RL, Wang Q, Carro A, Verhaak RG, Squatrito M (2017) GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro Oncol 19:139–141. https://doi.org/10.1093/neuonc/now247

Article  CAS  Google Scholar 

Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H (2011) Glutamate release by primary brain tumors induces epileptic activity. Nat Med 17:1269–1274. https://doi.org/10.1038/nm.2453

Article  CAS  Google Scholar 

Bunda S, Heir P, Metcalf J, Li ASC, Agnihotri S, Pusch S, Yasin M, Li M, Burrell K, Mansouri S et al (2019) CIC protein instability contributes to tumorigenesis in glioblastoma. Nat Commun 10:661. https://doi.org/10.1038/s41467-018-08087-9

Article  CAS  Google Scholar 

Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. https://doi.org/10.1056/NEJMoa1402121

Article  CAS  Google Scholar 

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401–404. https://doi.org/10.1158/2159-8290.CD-12-0095

Article  Google Scholar 

Chan AK, Pang JC, Chung NY, Li KK, Poon WS, Chan DT, Shi Z, Chen L, Zhou L, Ng HK (2014) Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors. Mod Pathol 27:332–342. https://doi.org/10.1038/modpathol.2013.165

Article  CAS  Google Scholar 

Chittaranjan S, Chan S, Yang C, Yang KC, Chen V, Moradian A, Firme M, Song J, Go NE, Blough MD et al (2014) Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity. Oncotarget 5:7960–7979. https://doi.org/10.18632/oncotarget.2401

Article  Google Scholar 

Dissanayake K, Toth R, Blakey J, Olsson O, Campbell DG, Prescott AR, MacKintosh C (2011) ERK/p90(RSK)/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicua. Biochem J 433:515–525. https://doi.org/10.1042/BJ20101562

Article  CAS  Google Scholar 

Fores M, Simon-Carrasco L, Ajuria L, Samper N, Gonzalez-Crespo S, Drosten M, Barbacid M, Jimenez G (2017) A new mode of DNA binding distinguishes Capicua from other HMG-box factors and explains its mutation patterns in cancer. PLoS Genet 13:e1006622. https://doi.org/10.1371/journal.pgen.1006622

Article  CAS  Google Scholar 

Gleize V, Alentorn A, Connen de Kerillis L, Labussiere M, Nadaradjane AA, Mundwiller E, Ottolenghi C, Mangesius S, Rahimian A, Ducray F et al (2015) CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas. Ann Neurol 78:355–374. https://doi.org/10.1002/ana.24443

Article  CAS  Google Scholar 

Hoffrogge R, Mikkat S, Scharf C, Beyer S, Christoph H, Pahnke J, Mix E, Berth M, Uhrmacher A, Zubrzycki IZ et al (2006) 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 6:1833–1847. https://doi.org/10.1002/pmic.200500556

Article  CAS  Google Scholar 

Jimenez G, Shvartsman SY, Paroush Z (2012) The Capicua repressor–a general sensor of RTK signaling in development and disease. J Cell Sci 125:1383–1391. https://doi.org/10.1242/jcs.092965

Article  CAS  Google Scholar 

Jin Y, Ha N, Fores M, Xiang J, Glasser C, Maldera J, Jimenez G, Edgar BA (2015) EGFR/Ras signaling controls drosophila intestinal stem cell proliferation via capicua-regulated genes. PLoS Genet 11:e1005634. https://doi.org/10.1371/journal.pgen.1005634

Article  CAS  Google Scholar 

Liao S, Davoli T, Leng Y, Li MZ, Xu Q, Elledge SJ (2017) A genetic interaction analysis identifies cancer drivers that modify EGFR dependency. Genes Dev 31:184–196. https://doi.org/10.1101/gad.291948.116

Article  CAS  Google Scholar 

Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B (2019) WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res 47:W199–W205. https://doi.org/10.1093/nar/gkz401

Article  CAS  Google Scholar 

Lim JKM, Delaidelli A, Minaker SW, Zhang HF, Colovic M, Yang H, Negri GL, von Karstedt S, Lockwood WW, Schaffer P et al (2019) Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance. Proc Natl Acad Sci U S A 116:9433–9442. https://doi.org/10.1073/pnas.1821323116

Article  CAS  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  Google Scholar 

Meek SE, Lane WS, Piwnica-Worms H (2004) Comprehensive proteomic analysis of interphase and mitotic 14–3-3-binding proteins. J Biol Chem 279:32046–32054. https://doi.org/10.1074/jbc.M403044200

Article  CAS  Google Scholar 

Okimoto RA, Breitenbuecher F, Olivas VR, Wu W, Gini B, Hofree M, Asthana S, Hrustanovic G, Flanagan J, Tulpule A et al (2017) Inactivation of Capicua drives cancer metastasis. Nat Genet 49:87–96. https://doi.org/10.1038/ng.3728

Article  CAS  Google Scholar 

Padul V, Epari S, Moiyadi A, Shetty P, Shirsat NV (2015) ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas. Genes Chromosomes Cancer 54:725–733. https://doi.org/10.1002/gcc.22283

Article  CAS  Google Scholar 

Park JW, Sahm F, Steffl B, Arrillaga-Romany I, Cahill D, Monje M, Herold-Mende C, Wick W, Turcan S (2021) TERT and DNMT1 expression predict sensitivity to decitabine in gliomas. Neuro Oncol 23:76–87. https://doi.org/10.1093/neuonc/noaa207

Article  CAS  Google Scholar 

Park JW, Wollmann G, Urbiola C, Fogli B, Florio T, Geley S, Klimaschewski L (2018) Sprouty2 enhances the tumorigenic potential of glioblastoma cells. Neuro Oncol 20:1044–1054. https://doi.org/10.1093/neuonc/noy028

Article  CAS  Google Scholar 

Robert SM, Buckingham SC, Campbell SL, Robel S, Holt KT, Ogunrinu-Babarinde T, Warren PP, White DM, Reid MA, Eschbacher JM et al (2015) SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Sci Transl Med 7:286–289. https://doi.org/10.1126/scitranslmed.aaa8103

Article  CAS  Google Scholar 

Sahm F, Schrimpf D, Jones DT, Meyer J, Kratz A, Reuss D, Capper D, Koelsche C, Korshunov A, Wiestler B et al (2016) Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol 131:903–910. https://doi.org/10.1007/s00401-015-1519-8

Article  CAS  Google Scholar 

Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, Shimamura T, Niida A, Motomura K, Ohka F et al (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458–468. https://doi.org/10.1038/ng.3273

Article  CAS  Google Scholar 

Tanaka M, Yoshimoto T, Nakamura T (2017) A double-edged sword: the world according to Capicua in cancer. Cancer Sci 108:2319–2325. https://doi.org/10.1111/cas.13413

Article  CAS  Google Scholar 

Tseng AS, Tapon N, Kanda H, Cigizoglu S, Edelmann L, Pellock B, White K, Hariharan IK (2007) Capicua regulates cell proliferation downstream of the receptor tyrosine kinase/ras signaling pathway. Curr Biol 17:728–733. https://doi.org/10.1016/j.cub.2007.03.023

Article  CAS  Google Scholar 

Venteicher AS, Tirosh I, Hebert C, Yizhak K, Neftel C, Filbin MG, Hovestadt V, Escalante LE, Shaw ML, Rodman C et al (2017) Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science. https://doi.org/10.1126/science.aai8478

Article  Google Scholar 

Wang B, Krall EB, Aguirre AJ, Kim M, Widlund HR, Doshi MB, Sicinska E, Sulahian R, Goodale A, Cowley GS et al (2017) ATXN1L, CIC, and ETS transcription factors modulate sensitivity to MAPK pathway inhibition. Cell Rep 18:1543–1557. https://doi.org/10.1016/j.celrep.2017.01.031

Article  CAS  Google Scholar 

Weissmann S, Cloos PA, Sidoli S, Jensen ON, Pollard S, Helin K (2018) The tumor suppressor CIC directly regulates MAPK pathway genes via histone deacetylation. Cancer Res 78:4114–4125. https://doi.org/10.1158/0008-5472.CAN-18-0342

Article  CAS  Google Scholar 

Wong D, Lounsbury K, Lum A, Song J, Chan S, LeBlanc V, Chittaranjan S, Marra M, Yip S (2019) Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer. Oncogene 38:273–290. https://doi.org/10.1038/s41388-018-0427-5

Article  CAS  Google Scholar 

Yang R, Chen LH, Hansen LJ, Carpenter AB, Moure CJ, Liu H, Pirozzi CJ, Diplas BH, Waitkus MS, Greer PK et al (2017) Cic loss promotes gliomagenesis via aberrant neural stem cell proliferation and differentiation. Cancer Res 77:6097–6108. https://doi.org/10.1158/0008-5472.CAN-17-1018

Article  CAS  Google Scholar 

Ye ZC, Sontheimer H (1999) Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59:4383–4391

CAS  Google Scholar 

Yip S, Butterfield YS, Morozova O, Chittaranjan S, Blough MD, An J, Birol I, Chesnelong C, Chiu R, Chuah E et al (2012) Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. J Pathol 226:7–16. https://doi.org/10.1002/path.2995

Article  CAS  Google Scholar